A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered.
While these results are only preliminary, the study published in the British Journal of Cancer today (Wednesday), found that sensors could distinguish between the breath of healthy patients and those who have cancer.
The sensors could also identify the type of cancer - lung, breast, bowel or prostate - irrespective of a patient's age, gender or lifestyle.
But this study is at a very early stage; further tests with larger samples would be needed to determine the strength of the link between breath and cancer detection.
The results could potentially lead to the development of a low cost, easy-to-use, non-invasive and portable test to help diagnose cancer earlier in patients - something which doctors often struggle to do because of a shortage of reliable methods.
Professor Abraham Kuten, co-author of the study who is based at Technion Israel Institute of Technology, said: "This study shows that an "electronic nose" can distinguish between healthy and malignant breath, and can also differentiate between the breath of patients with different cancer types.
"If we can confirm these initial results in large-scale studies, this new technology could become a simple tool for early diagnosis of cancer along with imaging
"It could also be an easy way to assess and monitor the effectiveness of cancer treatment and detect relapses earlier."
The study examined the breath of 177 volunteers - a mix of patients with different stages of lung, breast, bowel or prostate cancer and those who were healthy.
As a cancer grows, the surface of cells emits chemicals; the research found that sensors could be used to detect these chemicals in the breath.